pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4651 |
Genomic Coordinates | chr7: 75915197 - 75915269 |
Description | Homo sapiens miR-4651 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4651 | ||||||||||||||||||||||||||||||
Sequence | 10| CGGGGUGGGUGAGGUCGGGC |29 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DCX | ||||||||||||||||||||
Synonyms | DBCN, DC, LISX, SCLH, XLIS | ||||||||||||||||||||
Description | doublecortin | ||||||||||||||||||||
Transcript | NM_000555 | ||||||||||||||||||||
Other Transcripts | NM_178151 , NM_178152 , NM_178153 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DCX | |||||||||||||||||||||
3'UTR of DCX (miRNA target sites are highlighted) |
>DCX|NM_000555|3'UTR 1 AGGAGGGGAGAGTGCTCAGAGTCCAGAGTACAAATCCAAGCCTATCATTGTAGTAGGGTACTTCTGCTCAAGTGTCCAAC 81 AGGGCTATTGGTGCTTTCAAGTTTTTATTTTGTTGTTGTTGTTATTTTGAAAAACACATTGTAATATGTTGGGTTTATTT 161 TCCTGTGATTTCTCCTCTGGGCCACTGATCCACAGTTACCAATTATGAGAGATAGATTGATAACCATCCTTTGGGGCAGC 241 ATTCCAGGGATGCAAAATGTGCTAGTCCATGACCTTTCAATGGAAAGCTTAGGTGCCTGCGTTATATTTGCCCTGTCTAA 321 TTTTGCCCATACAGTCTTCCTTCTGTAGAGGGCTGTTTACATATACAGCACTTAAAATGTTTGTGTGGGAAAAAAAAAAC 401 TCATTGGCAGATCCAAGAATGACAAACACAAGTGCCCCTTTTCTCTGGATCTCAAGAATGGTGGAGGACCCTGGAAGGAC 481 AGCAAGGCAGCTCCCCAGCCTCACTCTTCACTCCTGATTGAGGCCCGGGTTTGTTGTCCAGCACCAATTCTGGCTGTCAA 561 TGGGGAGAAATAAACCAACAACTTATAATTGTGACACCAGATGCTTAGGATCCTGGTGCTGGGTTAGCTAAGAGAATAGA 641 CAGAATTGGAAAATACTGCAGACATTTCCGAAGAGTTTATAAAGCACAGTGAATTCCTGGTCAATCTCTCCACTGAGGCA 721 ATTTGGAATCAATAAGCAATTGATAATAGTTTGGAGTAAGGGACTTCATATACCTGATTCCTCTAGAAGGCTGTCTAACA 801 TACCACATGATTACATGAACTGTATGGTATCCATCTATCTCTGTTCTATTGAATGCCTTGTTAACAGCCAACACTGAAAA 881 CACTGTGAGAATTTGTTTTCAGGTCTGACACCTTTCAGTCTCTTTTTATAGCAAGAAATCAATATCCTTTTTATAAAAAT 961 TCATGTCTGTATTTCAGGAGCAAACTCTTCAGGCTCCTTTTTTATAAACTGGTGATTTTTCTTTTGTCTAAAAAACACAT 1041 GAAGAAAATTTACCAAAAAAAAAAAAAAAAGCAGAAGAATAATGTAGTTTAGAAATTATGCTGTCACTGCCAAACAGTAA 1121 CCTCCAGGAGAAAACAAGATGAATAGCAGAGGCCAATTCAATAGAATCAGTTTTTTGATAGCTTTTTAACAGTTATGCTT 1201 GCATTAATAATTTCAATGTGGACCAGACATTCTAATTATATTTTAAATGAAATGTTACAGCATATTTTAAGCAACTCTTT 1281 TTATCTATAATCCTAATATTTCATACTGAAGACACAGAAATCTTTCACTTGTCTTTAACATTAGAAAGGATTTCTCTTTA 1361 CTAAGGACTGATCATTTGAAATAGTTTTCAGTCTTTTGAGATACAGGTTTATAACACTGCTTTTTTTTTTCTGTAATCAT 1441 AGCCCATAATGGCAAAGACAACTAAATTTAAGTGAAGGTCATGCATGCCAATTCTGTGTTTGCTTTTAGCAGATATGAAG 1521 ATTTCCTTATTTCTTTGTAATTGTGCAGATATTTTGAAAGGCACAGCATTCGAAGCCAAGCTGCTGTTTGGCTACTGAAT 1601 GGCTTGCAGTTGTTCCTCCACTCTAAATGGAATGAGCTTGCTGTGTGTGTGTGTGGTGGTGGTGGGAGGGGGTGGTGCAT 1681 GTGTGTGTGTGTGTGTGCATCTGCAGCTGCTTCAAAATTAGGAAATACTACAGGACACCCCTGTAATGGATTGGTGGCAA 1761 CTGGGTGGCACTGCTGATGTGCACTGTGTAGGGGGGAACCCAGTGGTGGTGGGGTAGCTCAGATGCCCCTAGACAAGCTT 1841 CAGATGTCTGTAGCTACCAGAAACATTTTCGGTTCAGGAAAAGTGAGATGATGGTAGTACTGGTTTCTGGTGAAATTGAA 1921 GAACCCCAAATGATGAGGATCTCTTTTTGCCCCCTCTCCTTTTTTTGTAGACCCATTCAAAACCATTAATAAGCCCATTT 2001 TACTAAGCCCCTATTTCTTTCTAGAAGCTCAGGGTTTTCTTAGTGCCTCCCAGAACATTTTGTAGTTAATTGGGAAAAAG 2081 TGATACTTGGATTAGGGGGTGTGGGCATAAAGAATGGTGGGAGGCCTGATTTTAAACTTCAGGCCAGAACCCCCAATGAC 2161 TCCACCCATAGTCTCACTTTAGGTCTCATTTAGTCCATCACCTTTATTTTAAGTTGAGGAAGTGGAGGCTGGTAAAGAGC 2241 AGGACCAGAGGAAGAATCCAGATTTCCTTATGCTTGGGCCTCACACTAGCTCTCTGAGTATTTCCTTGATTGCGGTATAT 2321 GTACTACTAGAAAATACCAAATGGATATATTTTCTTTAGGATAACCTTTGAACCAACAATCTTCAATAACAATAGTACAT 2401 CTTCCATCTTACTTTTAATCGAGTATAAGGAAATGTTTCTTTATGGCCATTTTGGAGGGAGCAGGGGATGAGGCTTGGCA 2481 TAGTCCAAAATTTAAGTCTCCAATAATTAATTGCATTTTAAATTGGCCCACTTTCAAGGCAATTTTTTTTGTGTGTCTGT 2561 AACTGAGCTCCTCCACCCCTGTCATTCACTTCCAATTTTACCCAATCCAATTTTAGCACTCAAGTTCCATTGTGTTAATT 2641 TCTGCACGGTCAACAAACATCAAGTCAGCAAGCATTTGCCACCACTCCCTATACTTCTCCCTCCTTCTTACACACACACA 2721 CACACACACACACACAATCCATCTCTTGCTTGTTCCTACCTCCTGATTTTTCTTCCCTACAGAAATAGAAATAGGGACAA 2801 AGAAGGGGAAAATGTATATATTGGGGCTGGGCTGAACAACTAACTTCATAAGTAGTATTAACTAGGGGTAAATTGAGAGA 2881 AAAGCTCCTTTTCTCTTCACTGTTTTGGAAAGGATAGCCATTAGCATGACTGCTTTGTGTCCTTATGGACTTTAGTATTA 2961 GCCTAGATTGAATTATAGCGTTTTCTAGCTGGAAGGAACCTTAAGATCACATCATCTACTCCTCTACTCCAAATTTCTCA 3041 TTCTTCAGGCCAGGAAACCGAGACACAGAGGTAAAGTAATTTCCCCAAGGTCACACAGCTGGCTGGGGCAGGATTGGGTT 3121 TACAACCCACATCTCCTGGCTCTTATTCCAGGGCCTTTTCCCACTAAGTAGTATTGCCTTCCATTAGGCTCCTGAGAGTT 3201 ATTTCTCAGGGTCATGTTGCATCTTGGAGCCACATGCTGCTGCCCTGATCTCAGTGGGAAATCCACCCAGCAACCTAATA 3281 CAGCCCCTTTTCCCTGCATTCACCTGGTTCCCATCCACATGGGTTGCAGATGTCCTTGAAGAGAGTGAGGCATTGAGGGC 3361 CAATAGGAGCAATGGGGTCCCTGGCCTTGTCCATCTGATTCAGGAGATCACTGCTCCATCGTGAGGAGCCCTCTGAATAG 3441 CCCCCCACTGAATGCTTGCCTTGCCCAAATGGAATGGAGGAAGATTGATTTTCTCCATCAGTTCACCTTGTGTCATCTCA 3521 TAATGGTTGGTCTTTCCAGGCTGAGGGAAATGTTTCTTGTTTCCAGAGTAGAAAAAGAAAGAGTGGAACAATAGCTTTGT 3601 TCATCCTAACTTTCTGAGATGGCTTTTCAACATTTTAAAAAAACTAGTGTGGCTACCATTCACTGGCAATGATTTCTTTT 3681 AGAATATGGGAGTAAGATGAGCTAGAGAAAATAACCTGGTCTCACTGTGGTTGCCCTCATCCACAATGTCCCCAAAGCCA 3761 TCCTGCTCTGATGAGGACAATTTCCAGGTATAAGCAAGGGGCTTTGTGACAAAAATGTACCCTGGCTGATGTTAAACATT 3841 GGCTCCTGTGTTTGCACCAAAATAGCAAGCTGTGTGCTCTATACACTCTTCCCATCGTCTTGTGTACACTGCTCCTGTGG 3921 CCTTCCACAGCAGAAACCAGGGCAAAAGGGTCCAAACACATGGTTTTCCTTGCTGCAAGGCTCTTCCTGGGAACTAAGGG 4001 GGTATTTATTAGTTCAGTTCTAAGAGACCTCCTTCTGGGCTTACCCCACTCCTCAGGTACTTCTCTCTCCTTCCTCCTTC 4081 TCCTCCACAGTCACAAGTAACCAAGGAACCTGAAAGTGGATGTGTAGCTATTTGAAGAAGGCAAGGAACCCTGAGATTCT 4161 TCTTTGAATCCTCTAGTCCAAGTCTTAGACCAGTGATTGGTGCTTACCTTGAACAAAATTTTGTCTGTGTTCCTAATCCC 4241 TTCAATACTCTGGGTACAATGCTCCCAATCACCCTGCACATTTGATTCTAAATGGCTTTTATTTTTTAAAAATCCATATC 4321 CCTAGGACAAGAGAACAGGATGCCTATATCCCCAAAATGAGCTCCAGGACACTGATGGGAATGATCCCAAAGATCACCCC 4401 ACCTCAGAAACGTCTGTGCCAAGAGACTTCCCCAGATAGAAACACTGGGACAGTGGTTTGAACGACTTCTTTTATGGTTG 4481 TCCAGTTTGCTATGGAAATAAAAGGCATTGATTTTTTAAAAAGATGATTGGAACCTGTCTTTGGCCACATAGGGCCACTT 4561 GGATCCATTTCCAGGCCTTACTCATATATTGCCTTCACTGAAGGGCTTTGGCTTTAAGTCCCAGACTGGTCTCCCAAGTG 4641 AACCATAAGTGTTTTGGAGCTCATCTGGGGTGAGGCATGAGAATGTTGCCCCATCTATCCCTTCAGGAAAAGGTGCCTTC 4721 CCTCCCTTTCTCCTAAAGCCTGGTCCCCAGAAATTGTTTTTGTCTCCAAAAGTCTAGTATGGTCTTTATACACCCAGACT 4801 CTTAGTGTTGCGTCCTGCCTTGTTTCCTTGTTAAGGATCTATGCAGACCTCCCGCTTTGGCTTAGCTAGCGTGACATTGG 4881 CTATCATTTGACAAGACTAACTTTTTTTTTTTTTTTTTTTTGACTGAGTCTCCCTCTGTCACCTAGGCTGGAGTGCAGTG 4961 GCACAATCTTGGCTCGCTGCAACCTTCACCCTTCACCTCCCAGGTCGAAGCGATTCTCCTGCCTCAGTCTCCCGAGTAGC 5041 TGGGATTACAGGCGTGCGCCACCAAATCTGGCTATTTTTTTATTATTATTATTTTTAGTAGAGATGGGGTTTCACCATGT 5121 TGGCCAGACTGGTCTTGAACTCTTGGCCTCAAATTATCTGCCCACCTCGGCCTCCCAAAGTGCTGGGATTACAGGCATGA 5201 GCCACCATGCCCAGCTGACAAGACTAATTTTTTATCCCTTGGTTTATTGGCTTCAACATCTTCTGGAATCAGAGGTGATT 5281 TTTTCTTACCTTGGATGCCTGAGACTAGGGGAGTATAGAATTCCAATTGGTAATTAAGGCATCTTTCTGCTCCTGATCAG 5361 AAGGGCAGGTTAGTTGGGAGAGGTCAGATGGCACAACAGAAGTCACCTTGTAAGTAAGGCAAAGACTTGAAGGCATTAGC 5441 GTTTCTCATTACTAGGTCAATAACCTGAGGGAATCAATGGCTTTTTGCCGCTCTACCTCTTGTGTATCTCTTTGACTTTT 5521 CTTTCTCTGTCTAGTTTCCTCTGTTCTCAGTTTATATTCTATGTTATCAGTCTCTCTTTCCACAGTACAAACATCCATCC 5601 TTTCTCCTGTGCAATTCTGTCTCTCCCTCTTATTATCTTTATTTGTACTTTTTCCTTCCTCCCTGTCTAGGCATTGGGCA 5681 TGTGCCTCTTCTTAGCCTGTGATTTTGCCTTGGGACTGATGATAAATTATTTCCAGATTCAATCAGCCCTGGTCCTACCC 5761 CAGTCCAATCAGAAGTATGTTGGTGGGAATCAACCTGATCCTGGCCCTTTCTTCTTCTCCATTTTCATTCGTAATCCCCC 5841 TCAGCAGATCTTTACAAGCAGTTTCCTTATAGCTCATGTATCTTTAGGTCTTTGCCTTCCAAGCACTGTACAGAATACTT 5921 TGTGGTTCCTTTTTAGTCTGACATTTTGTGGAGCAGTGAAGCGTGCTCAGAGACATAATCAGCTGAAGAGAAAAAATCCA 6001 CCCATGGATTTATATCAGCTAAATACTAATAATTGATTTTGTTTGATGTGCCCATAATTTTTAAAGCTGCAATATAATAT 6081 AATGAGGGACCACAGGTAATTTCTCCTGTCATTTGTTTTGGCTGGATGGGGGTGGGGGAGTAATTGCTTAAAGTTTTACC 6161 ATTACACATTAAACTCTCTATAATAATCTTGTTTGGGGCTTGCTAACTGTTGAGCTGTTTTAACTAAACTGGTAGGCAAT 6241 CGGAGTTGATTTAAATGAAAAGATAATTTAACAAATCTATACTATAAAAAGAGACATTTGCTTAATTGACATGTATTTTT 6321 TCCTTCTGAGTCACCTAAACATTTACTCTTGACACCAACTGTTCATGATACTGAATAGACAGTCCATATAAGAGAAATTA 6401 GTGGACCTAAAGAAGCCAGATTGTAGGTGTTAATTTATTAAACAGAGTGCAAAGCCCTTGGAAATGTCACTGCTTGGCAA 6481 TACCATATGGAATGCCAAAATTTACAATGACTTTTCTTTATAAGTTATCCAAAAGGGATTTGAACAAGTAAGAGGTTATG 6561 CCAAAATGTCTCCAATGTATGGTCCTGTAATATATTGCAGCTTGAAGCCAATGATCCCTTATGACTTGTATACAACTAAT 6641 GCATGTTTTATTGAATTTTGCATTTCCCACGTGTGGTAAGTTCTTTAAAATGTTTTTGATCACCTTTTTGTGCCATTAAA 6721 CTTGTACAGAAAATGTTTTTATGGCCATTTTCAAAGGGAGAAAGTTTAAAATGGAAACAGCCCACCCTTTCTGCCCTATA 6801 GCTGTAGTTAGAATTGAGTACCTGTAGCAAAACAGCTGTAATTGGTGGTTGTAGTGTTAGAGGTGTTAGCTTGCTAGTGA 6881 CTAGCTTTGGAGAGTAAATGCATGGTATTGTACATCACATTTCTTAACTCGTTTTAACCTCTGAAAAGAATATATTCTTC 6961 TTTGTAGTCCTTCTTCCCACCCCCTTGCCCTCTCCCTCTCCCTGCTCCCAGTTGTCTTACAGTTGTAAATATCTGATTTG 7041 AGGCCCAATAACTCTTGCCAAGTAAAGTCAGCAAACAACAAACAAACCAAAATGTGGGGAAAAGGCATTTCTCAACCATC 7121 TCTCAGCAGTTATTGATCATTTCTTAAGGAACAGCATTGTGATCAAAGACTCAACTTTACGTAAAAATCAGTGGTAAATT 7201 GGGGTTGTATTTGGCCATTTGATTACATTTCAGGATTGAATAGTTTTCAGAATCACATGTAATCCAAAGACAGTAGGTAG 7281 TGATGTCCCTTATCCCTGCAGCTGTTTTAAGATAGAGACCTCAGAAGACTCTGCTTGACCGATGACCAATAATTATTTGA 7361 AAAAAAAAGAAAAAATGAGAGAAATAAAACAGATATTTAAGAACTTTAGCCACCTATTTAGAATAGTTATAGCCAGAAAA 7441 AAAAACAAGGGCATGAGTTCAAATGCATTACTATCAGTGTCCTAGGCAATACCTAACCTACTCTGAAATTGTGATTCAAA 7521 AGCAGTATTTCAAGAGGCATTCTCCTTTTTTGGTTTGCTGACCCCACTTGGACTGGTAGGTTTGGTGAGGCCCCCATAAA 7601 CCAGCTGGAGCAGACCCTTTTCATCTCCTGTGCCTGTAACACCCCTCTTCCCCCACCCCCTCCGCAATTCAATGAGGGCT 7681 TTCTTGGGTCAGAGGACTTCAAGGTTGTCTAGAGAAGTTTGCCATGTGTGTAAGGTGCTGTGAACTGTGAGTGCTGAAGA 7761 TTCGCAGCATTCAATACCAGGCAGCCAAAGAGCTGCTCTTGCAATTATTTTGGCTCTCAAGCTCTGTTCTTCATCGCATT 7841 CTCATTTCTGTGTACATTTGCAAGATGTGTGTAATGTCATTTTCCAAAAATAAAATTTGATTTCAATAAAAAAAAAAAAA 7921 AAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 , TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000356915.2 | 3UTR | CCCCCUUGCCCUCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000356915.2 | 3UTR | CCCCCUUGCCCUCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
121 hsa-miR-4651 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT066212 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT113270 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | 2 | 2 | ||||||||
MIRT115795 | CAPN15 | calpain 15 | 2 | 2 | ||||||||
MIRT125296 | MID1IP1 | MID1 interacting protein 1 | 2 | 2 | ||||||||
MIRT145419 | ANKRD13B | ankyrin repeat domain 13B | 2 | 2 | ||||||||
MIRT153779 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT189384 | TXLNA | taxilin alpha | 2 | 4 | ||||||||
MIRT451063 | PNMAL2 | paraneoplastic Ma antigen family member 8B | 2 | 2 | ||||||||
MIRT451142 | C19orf53 | chromosome 19 open reading frame 53 | 2 | 2 | ||||||||
MIRT452374 | LY6E | lymphocyte antigen 6 family member E | 2 | 4 | ||||||||
MIRT452788 | FAM136A | family with sequence similarity 136 member A | 2 | 2 | ||||||||
MIRT452985 | CABP4 | calcium binding protein 4 | 2 | 2 | ||||||||
MIRT453231 | FTSJ3 | FtsJ RNA methyltransferase homolog 3 | 2 | 2 | ||||||||
MIRT453824 | SAA1 | serum amyloid A1 | 2 | 2 | ||||||||
MIRT454136 | FOXRED2 | FAD dependent oxidoreductase domain containing 2 | 2 | 2 | ||||||||
MIRT455104 | NKX2-2 | NK2 homeobox 2 | 2 | 6 | ||||||||
MIRT455250 | DDX39B | DExD-box helicase 39B | 2 | 10 | ||||||||
MIRT456899 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT457099 | DCX | doublecortin | 2 | 2 | ||||||||
MIRT457761 | ZC3H12B | zinc finger CCCH-type containing 12B | 2 | 4 | ||||||||
MIRT458539 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 2 | 2 | ||||||||
MIRT459011 | UQCRH | ubiquinol-cytochrome c reductase hinge protein | 2 | 2 | ||||||||
MIRT459197 | RCE1 | Ras converting CAAX endopeptidase 1 | 2 | 2 | ||||||||
MIRT459295 | PHYKPL | 5-phosphohydroxy-L-lysine phospho-lyase | 2 | 2 | ||||||||
MIRT459466 | MUC17 | mucin 17, cell surface associated | 2 | 4 | ||||||||
MIRT459598 | KCNK3 | potassium two pore domain channel subfamily K member 3 | 2 | 2 | ||||||||
MIRT461274 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT464551 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT465253 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT465274 | TRIM28 | tripartite motif containing 28 | 2 | 2 | ||||||||
MIRT465402 | TP53 | tumor protein p53 | 2 | 2 | ||||||||
MIRT465877 | TMEM43 | transmembrane protein 43 | 2 | 4 | ||||||||
MIRT466234 | TMED10 | transmembrane p24 trafficking protein 10 | 2 | 2 | ||||||||
MIRT467027 | SRSF1 | serine and arginine rich splicing factor 1 | 2 | 4 | ||||||||
MIRT468320 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT468437 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468691 | SEC22C | SEC22 homolog C, vesicle trafficking protein | 2 | 4 | ||||||||
MIRT468863 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT469779 | RAB15 | RAB15, member RAS oncogene family | 2 | 2 | ||||||||
MIRT470314 | PPP6R1 | protein phosphatase 6 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT470765 | PNPLA6 | patatin like phospholipase domain containing 6 | 2 | 2 | ||||||||
MIRT472213 | NGFR | nerve growth factor receptor | 2 | 2 | ||||||||
MIRT472520 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT473281 | MFRP | membrane frizzled-related protein | 2 | 2 | ||||||||
MIRT473403 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT473521 | MAX | MYC associated factor X | 2 | 2 | ||||||||
MIRT474529 | KLHDC8A | kelch domain containing 8A | 2 | 2 | ||||||||
MIRT474631 | KLF16 | Kruppel like factor 16 | 2 | 2 | ||||||||
MIRT475130 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT475808 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478623 | CTDNEP1 | CTD nuclear envelope phosphatase 1 | 2 | 2 | ||||||||
MIRT479501 | CDH6 | cadherin 6 | 2 | 2 | ||||||||
MIRT479865 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT480132 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT480529 | C10orf76 | chromosome 10 open reading frame 76 | 2 | 2 | ||||||||
MIRT480774 | BMP2 | bone morphogenetic protein 2 | 2 | 2 | ||||||||
MIRT481423 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT481778 | APEX1 | apurinic/apyrimidinic endodeoxyribonuclease 1 | 2 | 2 | ||||||||
MIRT481821 | AP2M1 | adaptor related protein complex 2 mu 1 subunit | 2 | 2 | ||||||||
MIRT482698 | XRCC3 | X-ray repair cross complementing 3 | 2 | 2 | ||||||||
MIRT482976 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT483391 | SPATA6 | spermatogenesis associated 6 | 2 | 4 | ||||||||
MIRT483429 | RHOXF2B | Rhox homeobox family member 2B | 2 | 2 | ||||||||
MIRT483476 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT483687 | CYP11A1 | cytochrome P450 family 11 subfamily A member 1 | 2 | 2 | ||||||||
MIRT483803 | CYP2W1 | cytochrome P450 family 2 subfamily W member 1 | 2 | 6 | ||||||||
MIRT484335 | EPN1 | epsin 1 | 2 | 4 | ||||||||
MIRT484683 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT484966 | UCK1 | uridine-cytidine kinase 1 | 2 | 2 | ||||||||
MIRT485987 | YIPF2 | Yip1 domain family member 2 | 2 | 2 | ||||||||
MIRT486773 | SESTD1 | SEC14 and spectrin domain containing 1 | 2 | 4 | ||||||||
MIRT487372 | C10orf54 | V-set immunoregulatory receptor | 2 | 2 | ||||||||
MIRT487632 | ONECUT3 | one cut homeobox 3 | 2 | 4 | ||||||||
MIRT488080 | DLGAP3 | DLG associated protein 3 | 2 | 4 | ||||||||
MIRT488158 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT488463 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT490948 | PPM1F | protein phosphatase, Mg2+/Mn2+ dependent 1F | 2 | 2 | ||||||||
MIRT491719 | RTN4R | reticulon 4 receptor | 2 | 2 | ||||||||
MIRT492338 | SEPT8 | septin 8 | 2 | 2 | ||||||||
MIRT493038 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT493368 | KIAA1614 | KIAA1614 | 2 | 2 | ||||||||
MIRT499384 | PLCG2 | phospholipase C gamma 2 | 2 | 11 | ||||||||
MIRT499596 | ANKRD45 | ankyrin repeat domain 45 | 2 | 2 | ||||||||
MIRT499730 | USH1G | USH1 protein network component sans | 2 | 4 | ||||||||
MIRT500357 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT501691 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT504502 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | 2 | 2 | ||||||||
MIRT509579 | HIST2H2AB | histone cluster 2 H2A family member b | 2 | 4 | ||||||||
MIRT510610 | TPM3 | tropomyosin 3 | 2 | 2 | ||||||||
MIRT512803 | GLRX | glutaredoxin | 2 | 2 | ||||||||
MIRT513302 | SETBP1 | SET binding protein 1 | 2 | 2 | ||||||||
MIRT514005 | CECR2 | CECR2, histone acetyl-lysine reader | 2 | 4 | ||||||||
MIRT515701 | ZNF321P | zinc finger protein 321, pseudogene | 2 | 2 | ||||||||
MIRT518260 | LEAP2 | liver enriched antimicrobial peptide 2 | 2 | 2 | ||||||||
MIRT523183 | HIST3H3 | histone cluster 3 H3 | 2 | 2 | ||||||||
MIRT524051 | DNAJC8 | DnaJ heat shock protein family (Hsp40) member C8 | 2 | 2 | ||||||||
MIRT538642 | CCSAP | centriole, cilia and spindle associated protein | 2 | 2 | ||||||||
MIRT541497 | ADM | adrenomedullin | 2 | 2 | ||||||||
MIRT569279 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT570279 | ARPC3 | actin related protein 2/3 complex subunit 3 | 2 | 2 | ||||||||
MIRT570326 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT571451 | YKT6 | YKT6 v-SNARE homolog | 2 | 2 | ||||||||
MIRT571597 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT574894 | Plcg2 | phospholipase C, gamma 2 | 2 | 7 | ||||||||
MIRT607551 | GLI2 | GLI family zinc finger 2 | 2 | 2 | ||||||||
MIRT607694 | MAPK10 | mitogen-activated protein kinase 10 | 2 | 2 | ||||||||
MIRT609983 | PPARA | peroxisome proliferator activated receptor alpha | 2 | 2 | ||||||||
MIRT610076 | CRLF1 | cytokine receptor like factor 1 | 2 | 2 | ||||||||
MIRT610578 | CACUL1 | CDK2 associated cullin domain 1 | 2 | 4 | ||||||||
MIRT626322 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT634011 | RIF1 | replication timing regulatory factor 1 | 2 | 2 | ||||||||
MIRT642680 | KRT74 | keratin 74 | 2 | 2 | ||||||||
MIRT689717 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT691175 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT693169 | NPR1 | natriuretic peptide receptor 1 | 2 | 2 | ||||||||
MIRT697121 | OTUD5 | OTU deubiquitinase 5 | 2 | 2 | ||||||||
MIRT711817 | ELN | elastin | 2 | 2 | ||||||||
MIRT721551 | FXN | frataxin | 2 | 2 | ||||||||
MIRT721666 | SLFN12 | schlafen family member 12 | 2 | 2 | ||||||||
MIRT723760 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT737362 | FOXP4 | forkhead box P4 | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|